Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

New England Journal of Medicine,Volume 382, Issue 24, Page 2289-2301, June 2020.

https://www.nejm.org/doi/full/10.1056/NEJMoa1913147?af=R&rss=currentIssue

Source: New England Journal of Medicine - June 9, 2020 Category: Internal Medicine Authors: Manisha Balwani Eliane Sardh Paolo Ventura Paula Aguilera Peir ó David C. Rees Ulrich St ölzel D. Montgomery Bissell Herbert L. Bonkovsky Jerzy Windyga Karl E. Anderson Charles Parker Samuel M. Silver Siob án B. Keel Jiaan-Der Wang Penelope E. Stein Pa Source Type: research

More News: Internal Medicine | Porphyria